Last reviewed · How we verify
Inactivated Enterovirus Type 71 Vaccine — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Inactivated Enterovirus Type 71 Vaccine (Inactivated Enterovirus Type 71 Vaccine) — Sinovac Biotech Co., Ltd.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Inactivated Enterovirus Type 71 Vaccine TARGET | Inactivated Enterovirus Type 71 Vaccine | Sinovac Biotech Co., Ltd | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Inactivated Enterovirus Type 71 Vaccine CI watch — RSS
- Inactivated Enterovirus Type 71 Vaccine CI watch — Atom
- Inactivated Enterovirus Type 71 Vaccine CI watch — JSON
- Inactivated Enterovirus Type 71 Vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Inactivated Enterovirus Type 71 Vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/inactivated-enterovirus-type-71-vaccine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab